Id |
Subject |
Object |
Predicate |
Lexical cue |
T305 |
0-124 |
Sentence |
denotes |
Ping Yu et al. conducted a study on the therapeutic effect of LHQWC combined with Abidole in the treatment of mild COVID-19. |
T306 |
125-187 |
Sentence |
denotes |
A total of 295 patients were randomly divided into two groups. |
T307 |
188-366 |
Sentence |
denotes |
The control group (n = 148) was treated with Abidole (0.2 g per day) orally, and the observation group (n = 147) was treated with LHQWC (6 g, thrice daily) combined with Abidole. |
T308 |
367-622 |
Sentence |
denotes |
The results showed that the total effective rate of the observation group was significantly higher than that of the control group (80.95% vs 64.86%), and the rate of severe illness was significantly lower than that of the control group (14.29% vs 23.65%). |
T309 |
623-1011 |
Sentence |
denotes |
After 7 days of treatment, the scores for the main TCM syndromes (fever, fatigue, cough, dry throat, chest tightness) and the levels of C-reactive protein (CRP) and procalcitonin (PCT) in the observation group were significantly lower than those in the control group (p < 0.05), while white blood cells (WBC) and lymphocyte (LYM) were significantly higher than those in the control group. |
T310 |
1012-1228 |
Sentence |
denotes |
The effective rate of chest computerized tomography (CT) in the observation group was 69.39%, which was higher than that in the control group (62.84%), but the difference was not statistically significant (p > 0.05). |
T311 |
1229-1298 |
Sentence |
denotes |
There were no serious drug-related adverse reactions in either group. |
T312 |
1299-1567 |
Sentence |
denotes |
The results show that LHQWC combined with Abidole can effectively relieve clinical symptoms in patients with mild COVID-19, regulate the expression of related inflammatory factors, improve the curative effect and reduce the rate of severe illness (Yu P. et al., 2020). |